Status:
COMPLETED
Apneic Oxygenation by Transnasal Humidified Rapid Insufflation Ventilator Exchange Obstructive Sleep Apnea Patients
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Obstructive Sleep Apnea Syndrome
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of the study is to compare effectiveness of different methods of achieving oxygenation in obstructive sleep apnea patients. The investigators intend to compare transnasal humidified rapid-...
Detailed Description
With the increasing prevalence of obesity, the prevalence of OSA is also rising, ranging from 9% to 25% in the general adult population. Patients with OSA have features of an anatomically tricky airwa...
Eligibility Criteria
Inclusion
- patients aged between 18 and 75 years requiring general anesthesia
- American society of Anesthesiologists (ASA) physical status classification system: I - III
- diagnosed as OSA.
Exclusion
- Patients with chronic respiratory disease, uncontrolled hypertension, ischemic heart disease, congestive heart failure, increased intracranial pressure, gastroesophageal reflux disease,
- patients' arterial hemoglobin saturation \< 98% after preoxygenation,
- patients were nasal obstruction
- patients with previous or anticipated difficult facemask ventilation or intubation,
- patients with known allergy or contraindication to propofol, remifentanil, rocuronium, or midazolam.
- patients who were unable to give informed consent
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06581588
Start Date
September 1 2024
End Date
April 13 2025
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100000